查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1466509

計算生物學市場：按服務、應用和最終用途分類 - 全球預測 2024-2030

Computational Biology Market by Services (Contract, In-house), Application (Cellular Biological Simulation, Clinical Trials, Drug Discovery & Disease Modelling), End-Use - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

計算生物學市場規模預估2023年為62.5億美元，2024年達74.2億美元，預計2030年將達210.1億美元，複合年成長率為18.91%。

計算生物學是一個跨學科領域，它應用電腦科學、應用數學、統計學和生物資訊學的技術來解決生物學中的複雜問題、理解生物資料和模擬生物系統。它涵蓋了理論方法、資料分析、計算模擬技術和數學建模在生物學、行為和社會系統研究中的發展和應用。該技術的主要目的是深入了解生物系統的原理和動力學，並預測它們的行為和相互作用。計算生物學與生物資訊學領域密切相關，但傾向於關注理論方法和計算模型的發展。計算生物學市場是由藥物發現和個人化醫療需求不斷成長、生物資訊學領域的進步以及複雜生物資料量不斷增加所推動的。用於基因組學和蛋白​​質組學研究和開發的政府和私人資金也支持市場擴張。儘管存在成長潛力，但對專門計算基礎設施的需求、與計算工具相關的高成本以及缺乏分析生物資料的熟練專業人員正在阻礙計算生物學的發展。此外，資料安全和隱私問題以及醫療保健相關資料監管合規的複雜性也為市場普及帶來了障礙。然而，人工智慧和機器學習演算法的整合透過增強預測建模和資料分析能力，進一步為市場成長提供了利潤豐厚的機會。此外，人們對生物標記發現及其在精準醫學中的作用的日益關注為市場擴張帶來了新的機會。

主要市場統計
基準年[2023] 62.5億美元
預測年份 [2024] 74.2億美元
預測年份 [2030] 210.1億美元
複合年成長率（%） 18.91%

內部計算生物學處理敏感服務資料和獨特研究的優勢

在計算生物學的動態領域，基於合約的服務作為一種靈活的解決方案脫穎而出，適合尋求專業知識且無需全職工作的組織。這些服務由外部提供者和個人顧問提供，根據特定的計劃需求和時間表量身定做，因此您可以臨時或逐個計劃地依賴先進的分析技能、尖端演算法開發和自訂生物資訊軟體解決方案。有需要的公司來說，這是寶貴的資源。相較之下，內部計算生物學服務被整合到組織的永久營運結構中。這種方法可以對計算生物學專業知識進行一致的長期投資，並促進對公司特定研究領域和方法的深入了解。內部團隊熟悉組織的資料、目標和流程，從而使產出與業務的策略目標緊密結合。我們提供穩定且不斷發展的資源，可以適應您公司不斷變化的需求。

應用計算生物學在簡化藥物開發平臺方面的重要應用

細胞生物學模擬使用計算模型來模擬生物細胞的行為和交互作用。這些模擬有助於理解和預測細胞功能、生物行為以及對各種刺激的反應，對於基礎研究和應用生物醫學應用至關重要。該技術特別適合研究複雜的生化途徑以及在體外或體內進行成本高昂或技術上困難的電腦實驗。臨床試驗是為確定新藥、醫療設備或治療通訊協定在人體中的有效性而進行的實驗研究。計算生物學在臨床試驗設計和分析中發揮著至關重要的作用，提高了試驗設計、患者分層和資料分析的效率。藥物發現和疾病建模是計算生物學的重要應用，化合物的電腦輔助設計 (CAD) 和疾病途徑建模加速了新療法的發現。這些技術中的每一種都能夠探索廣泛的化學空間和複雜疾病的建模，識別新藥的潛在目標和分子。人體模擬軟體包含多種計算工具，旨在模擬人體的解剖和生理方面。這些模擬可用於多種應用，包括醫療設備設計、手術規劃和教育目的。臨床前藥物開發是藥物開發過程中臨床試驗領先的研究階段。使用In Silico模型和模擬工具來預測候選藥物的藥物動力學、動態和毒性。

擴大商業公司對計算生物學的採用，解決最終用途應用研究的挑戰

在學術領域，計算生物學工具主要用於研究和教育目的。重點是最尖端科技的可及性、學生和研究人員的易用性以及成本效益。學術機構通常需要廣泛的資料庫和計算能力來進行從進化生物學到系統生物學等多種研究。製藥和生物技術公司等商業組織正在優先考慮將計算生物學應用於藥物發現和開發、個人化醫療和農業基因組學。這些領域需要強大、擴充性的解決方案，重點是資料安全和智慧財產權保護。

區域洞察

美洲，尤其是北美的計算生物學市場正在呈現強勁成長。知名製藥公司的存在、先進的醫療基礎設施和嚴格的研發活動正在支持該地區的市場擴張。對基因組學和蛋白​​質組學的大規模投資進一步推動了對計算生物學解決方案的需求。美國仍然處於領先地位，這得益於政府的支持政策、產業與學術界合作的加強以及越來越多的生物資訊學課程，這些課程為該領域的熟練專業人員提供了支持。在私人和公共資金增加的推動下，特別是在歐洲，EMEA（歐洲、中東和非洲）地區的計算生物學市場正在大幅成長。有效的藥物開發法律規範和卓越的科學傳統正在推動該地區的市場進步。德國、英國和法國是主要貢獻者，重點關注生物技術和計算科學。中東正穩步迎頭趕上，這主要得益於政府對生技領域的戰略投資，而非洲正處於發展的早期階段。亞太地區正在成為計算生物學市場的動態成長中心。經濟的快速發展、醫療保健支出的增加以及生物技術產業的蓬勃發展是市場格局的特徵。由於政府的支持、對生命科學教育和研究的重視以及對個人化醫療日益成長的興趣，該地區國家為市場參與者提供了有利的機會。跨國合作和外國投資的湧入進一步凸顯了這個市場的特徵，使亞太地區成為一個充滿競爭和未來性的地區。

FPNV定位矩陣

FPNV定位矩陣對於評估計算生物學市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對計算生物學市場中供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

本報告對以下幾個方面提供了寶貴的見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開拓：我們深入研究利潤豐厚的新興市場，並分析其在成熟細分市場的滲透率。

3. 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。

5. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1.計算生物學市場的市場規模和預測是多少？

2.計算生物學市場預測期內需要考慮投資的產品、細分市場、應用和領域有哪些？

3.計算生物學市場的技術趨勢和法規結構是什麼？

4.計算生物學市場主要廠商的市場佔有率是多少？

5. 進入計算生物學市場的適當型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 個人化醫療的需求不斷成長
      • 生物資訊學研究的進展和臨床研究的增加
      • 在腫瘤治療中採用計算生物學
    • 抑制因素
      • 缺乏熟練的專業人員來操作計算工具
    • 機會
      • 加速生物資訊學和多尺度生物建模在細胞建模的應用
      • 增加對生物資訊學的資助和計算生物學領域的進步
    • 任務
      • 缺乏互通性和多平台功能，缺乏明確定義的標準
  • 市場區隔分析
    • 服務：受益於敏感資料和專有研究的內部計算生物學能力
    • 應用：計算生物學在簡化藥物開發平臺的重要應用
    • 最終用途：商業組織擴大採用計算生物學來應對應用研究挑戰
  • 市場趨勢分析
  • 俄羅斯-烏克蘭衝突的累積影響
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法規結構分析
  • 客戶客製化

第6章計算生物學市場：依服務分類

  • 合約
  • 公司內部

第7章計算生物學市場：依應用分類

  • 細胞生物模擬
  • 臨床試驗
  • 藥物發現與疾病建模
  • 人體模擬軟體
  • 臨床前藥物開發

第8章計算生物學市場：依最終用途

  • 學術的
  • 商業的

第9章美洲計算生物學市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區計算生物學市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲的計算生物市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 為年輕的加拿大研究人員提供新的資金，以在生物資訊學、計算生物學和健康資料科學領域建立職業生涯
    • Pluto 宣布獲得由 Silverton Partners 領主導的 370 萬美元種子輪融資
    • Accenture投資 Ocean Genomics 加速人工智慧藥物發現和個人化醫療開發

第13章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-433AB1DC289D

[193 Pages Report] The Computational Biology Market size was estimated at USD 6.25 billion in 2023 and expected to reach USD 7.42 billion in 2024, at a CAGR 18.91% to reach USD 21.01 billion by 2030.

Computational biology is an interdisciplinary domain that applies techniques from computer science, applied mathematics, statistics, and bioinformatics to solve complex problems in biology, understand biological data, and model biological systems. It encompasses the development and application of theoretical methods and data-analytical, computational simulation techniques, and mathematical modeling to the study of biological, behavioral, and social systems. The primary aim of this technology is to generate insights into the principles and dynamics of biological systems, as well as to predict their behaviors and interactions. Computational biology is closely related to the field of bioinformatics but tends to focus more on the development of theoretical approaches and computational models. The computational biology market is driven by the increasing need for drug discovery and personalized medicine, advancements in the field of bioinformatics, and the rise in the volume of complex biological data. Government and private funding for research and development in genomics and proteomics also support the market expansion. Despite growth prospects, the need for specialized computational infrastructure, high costs associated with computational tools, and a shortage of skilled professionals to analyze biological data hinder the scope of computational biology. Moreover, concerns regarding data security and privacy and the complexity of regulatory compliances for healthcare-related data create hurdles in market proliferation. However, an integration of artificial intelligence and machine learning algorithms is further presenting lucrative opportunities for market growth by enhancing predictive modeling and data analysis capabilities. Moreover, the rising focus on biomarker discovery and its role in precision medicine opens up new opportunities for the market's expansion.

KEY MARKET STATISTICS
Base Year [2023] USD 6.25 billion
Estimated Year [2024] USD 7.42 billion
Forecast Year [2030] USD 21.01 billion
CAGR (%) 18.91%

Services: Benefits of in-house computational biology capabilities to handle sensitive data or proprietary research

In the dynamic field of computational biology, contract based services stand out as a flexible solution for organizations seeking specialized expertise without the overhead of full-time employment. These services, offered by external providers or individual consultants, are tailored to meet the specific project demands and timelines, making them an invaluable resource for companies that require advanced analytical skills, state-of-the-art algorithm development, or custom bioinformatics software solutions on a temporary or per-project basis. In contrast, in-house computational biology services are integrated within an organization's permanent operational structure. This approach allows for a consistent and long-term investment in computational biology expertise, fostering a deep understanding of the company's specific research areas and methodologies. In-house teams are intimately familiar with the data, objectives, and processes of their organization, enabling them to align their output closely with the strategic goals of the business. They provide a stable and continually evolving resource capable of adapting to the company's changing needs over time.

Application: Significant applications of computational biology to streamline the drug development pipeline

Cellular biological simulation involves the use of computational models to simulate the behaviors and interactions of biological cells. These simulations help to understand and predict cellular functions, biological behaviors, and responses to various stimuli, which is critical for both basic research and applied biomedical applications. The technology is especially relevant for investigating complex biochemical pathways and in silico experimentation, which can be cost-prohibitive or technically challenging to perform in vitro or in vivo. Clinical trials are experimental research studies conducted to determine the efficacy of new drugs, medical devices, or treatment protocols on human subjects. Computational biology plays a pivotal role in the design and analysis of clinical trials, improving the efficiency of trial designs, patient stratification, and data analysis. Drug discovery & disease modeling are crucial applications of computational biology where computer-aided design (CAD) for drug compounds and modeling of disease pathways accelerate the discovery of new therapeutics. These methods enable the exploration of vast chemical spaces and the modeling of complex diseases, respectively, to identify potential targets and molecules for new drugs. Human body simulation software encompasses a broad set of computational tools designed to model anatomical and physiological aspects of the human body. These simulations are employed for a variety of applications, including medical device design, surgical planning, and educational purposes. Preclinical drug development is the phase of research that precedes clinical trials in the drug development process. It involves the use of in silico models and simulation tools to predict the pharmacokinetics, pharmacodynamics, and toxicity of candidate drugs.

End-Use: Growing adoption of computational biology in commercial entities to tackle applied research challenges

In academic settings, computational biology tools are primarily used for research and educational purposes. The emphasis is on accessibility to cutting-edge technology, ease of use for students and researchers, and cost-effectiveness. Academic institutions often require extensive databases and computational power for diverse research ranging from evolutionary biology to systems biology. Commercial entities, including pharmaceutical and biotech companies, prioritize the application of computational biology for drug discovery and development, personalized medicine, and agrigenomics. These sectors seek robust, scalable solutions with a strong emphasis on data security and intellectual property protection.

Regional Insights

The computational biology market in the Americas, particularly in North America, is exhibiting robust growth. The presence of established pharmaceutical companies, sophisticated healthcare infrastructure, and rigorous research and development activities are propelling the region's market expansion. Large-scale investments in genomics and proteomics are further spurring demand for computational biology solutions. The United States remains at the forefront, backed by supportive government policies, substantial academic-industry collaborations, and an increase in bioinformatics-related courses that supply skilled professionals to the field. The EMEA region has been experiencing a significant surge in the computational biology market owing to increased funding by private and public entities, particularly in Europe. Efficient regulatory frameworks for drug development and a tradition of excellence in scientific research are driving the market's progress in this region. Germany, the UK, and France are major contributors with their strong focus on biotechnology and computational sciences. The Middle East is steadily catching up, largely due to strategic government investments in the biotech sector, while Africa is in the early stages of development. Asia-Pacific is emerging as a dynamic growth hub for the computational biology market. Rapid economic development, increasing healthcare expenditure, and a burgeoning biotechnology industry characterize the market landscape. Countries in the region are providing lucrative opportunities for market players owing to governmental backing, a focus on education and research in the life sciences, and a rising emphasis on personalized medicine. Cross-border collaborations and the inflow of foreign investments are further defining this market, positioning APAC as a competitive and high-potential region.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Computational Biology Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Computational Biology Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Computational Biology Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., BGI Group, Biomax Informatics AG, Chemical Computing Group Inc., Compugen Ltd., Dassault Systemes SE, DNAnexus, Inc., DNASTAR, Inc., Eurofins Scientific SE, Genedata AG, Illumina, Inc., Insilico Medicine, Instem Group, Nimbus Discovery Llc, Ocean Genomics, PerkinElmer, Inc., Pluto Bioinformatics, ProFound Therapeutics, QIAGEN N.V., Rosa & Co. Llc, Schrodinger, Inc., Simulation Plus Inc., SOPHiA GENETICS, Thermo Fisher Scientific Inc., Waters Corporation, and WuXi NextCODE.

Market Segmentation & Coverage

This research report categorizes the Computational Biology Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Services
    • Contract
    • In-house
  • Application
    • Cellular Biological Simulation
    • Clinical Trials
    • Drug Discovery & Disease Modelling
    • Human Body Simulation Software
    • Preclinical Drug Development
  • End-Use
    • Academics
    • Commercial
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Computational Biology Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Computational Biology Market?

3. What are the technology trends and regulatory frameworks in the Computational Biology Market?

4. What is the market share of the leading vendors in the Computational Biology Market?

5. Which modes and strategic moves are suitable for entering the Computational Biology Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising Need for Personalized Medicine
      • 5.1.1.2. Growing Bioinformatics Research and Increasing Number of Clinical Studies
      • 5.1.1.3. Adoption of Computational Biology in Oncology Therapeutics
    • 5.1.2. Restraints
      • 5.1.2.1. Dearth of Skilled Professionals to Operate Computational Tools
    • 5.1.3. Opportunities
      • 5.1.3.1. Accelerating Use of Bioinformatics and Multiscale Biological Modeling in Cell Modeling
      • 5.1.3.2. Increased Funding in Bioinformatics Coupled with Advancements in the Field of Computational Biology
    • 5.1.4. Challenges
      • 5.1.4.1. Insufficiency of Interoperability and Multiplatform Capabilities and Lack of Well-Defined Standards
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Services: Benefits of in-house computational biology capabilities to handle sensitive data or proprietary research
    • 5.2.2. Application: Significant applications of computational biology to streamline the drug development pipeline
    • 5.2.3. End-Use: Growing adoption of computational biology in commercial entities to tackle applied research challenges
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework Analysis
  • 5.9. Client Customization

6. Computational Biology Market, by Services

  • 6.1. Introduction
  • 6.2. Contract
  • 6.3. In-house

7. Computational Biology Market, by Application

  • 7.1. Introduction
  • 7.2. Cellular Biological Simulation
  • 7.3. Clinical Trials
  • 7.4. Drug Discovery & Disease Modelling
  • 7.5. Human Body Simulation Software
  • 7.6. Preclinical Drug Development

8. Computational Biology Market, by End-Use

  • 8.1. Introduction
  • 8.2. Academics
  • 8.3. Commercial

9. Americas Computational Biology Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Computational Biology Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Computational Biology Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. New Funds Available for Early Career Canadian Researchers Building Careers in Bioinformatics, Computational Biology, or Health Data Sciences
    • 12.3.2. Pluto Announces USD 3.7M Seed Round, Led by Silverton Partners
    • 12.3.3. Accenture Invests in Ocean Genomics to Accelerate AI-driven Drug Discovery and the Development of Personalized Medicines

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. COMPUTATIONAL BIOLOGY MARKET RESEARCH PROCESS
  • FIGURE 2. COMPUTATIONAL BIOLOGY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. COMPUTATIONAL BIOLOGY MARKET DYNAMICS
  • FIGURE 7. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS COMPUTATIONAL BIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS COMPUTATIONAL BIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC COMPUTATIONAL BIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC COMPUTATIONAL BIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. COMPUTATIONAL BIOLOGY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. COMPUTATIONAL BIOLOGY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. COMPUTATIONAL BIOLOGY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY CONTRACT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY CONTRACT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY IN-HOUSE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY IN-HOUSE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY CELLULAR BIOLOGICAL SIMULATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY CELLULAR BIOLOGICAL SIMULATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY DRUG DISCOVERY & DISEASE MODELLING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY DRUG DISCOVERY & DISEASE MODELLING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY HUMAN BODY SIMULATION SOFTWARE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY HUMAN BODY SIMULATION SOFTWARE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY PRECLINICAL DRUG DEVELOPMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY PRECLINICAL DRUG DEVELOPMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY ACADEMICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY ACADEMICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY COMMERCIAL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY COMMERCIAL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. AMERICAS COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 32. AMERICAS COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 33. AMERICAS COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 34. AMERICAS COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 35. AMERICAS COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 36. AMERICAS COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 37. AMERICAS COMPUTATIONAL BIOLOGY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 38. AMERICAS COMPUTATIONAL BIOLOGY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 39. ARGENTINA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 40. ARGENTINA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 41. ARGENTINA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 42. ARGENTINA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 43. ARGENTINA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 44. ARGENTINA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 45. BRAZIL COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 46. BRAZIL COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 47. BRAZIL COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 48. BRAZIL COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 49. BRAZIL COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 50. BRAZIL COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 51. CANADA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 52. CANADA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 53. CANADA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 54. CANADA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 55. CANADA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 56. CANADA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 57. MEXICO COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 58. MEXICO COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 59. MEXICO COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 60. MEXICO COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 61. MEXICO COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 62. MEXICO COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 63. UNITED STATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 64. UNITED STATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 65. UNITED STATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 66. UNITED STATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 67. UNITED STATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 68. UNITED STATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 69. UNITED STATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 70. UNITED STATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC COMPUTATIONAL BIOLOGY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC COMPUTATIONAL BIOLOGY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 80. AUSTRALIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 81. AUSTRALIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 82. AUSTRALIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 83. AUSTRALIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 84. AUSTRALIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 85. CHINA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 86. CHINA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 87. CHINA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 88. CHINA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 89. CHINA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 90. CHINA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 91. INDIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 92. INDIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 93. INDIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 94. INDIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 95. INDIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 96. INDIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 97. INDONESIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 98. INDONESIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 99. INDONESIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 100. INDONESIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 101. INDONESIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 102. INDONESIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 103. JAPAN COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 104. JAPAN COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 105. JAPAN COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 106. JAPAN COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 107. JAPAN COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 108. JAPAN COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 109. MALAYSIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 110. MALAYSIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 111. MALAYSIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 112. MALAYSIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 113. MALAYSIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 114. MALAYSIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 116. PHILIPPINES COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 117. PHILIPPINES COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 118. PHILIPPINES COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 119. PHILIPPINES COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 120. PHILIPPINES COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 121. SINGAPORE COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 122. SINGAPORE COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 123. SINGAPORE COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 124. SINGAPORE COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 125. SINGAPORE COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 126. SINGAPORE COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 128. SOUTH KOREA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 129. SOUTH KOREA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 130. SOUTH KOREA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 131. SOUTH KOREA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 132. SOUTH KOREA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 133. TAIWAN COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 134. TAIWAN COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 135. TAIWAN COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 136. TAIWAN COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 137. TAIWAN COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 138. TAIWAN COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 139. THAILAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 140. THAILAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 141. THAILAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 142. THAILAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 143. THAILAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 144. THAILAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 145. VIETNAM COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 146. VIETNAM COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 147. VIETNAM COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 148. VIETNAM COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 149. VIETNAM COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 150. VIETNAM COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 159. DENMARK COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 160. DENMARK COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 161. DENMARK COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 162. DENMARK COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 163. DENMARK COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 164. DENMARK COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 165. EGYPT COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 166. EGYPT COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 167. EGYPT COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 168. EGYPT COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 169. EGYPT COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 170. EGYPT COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 171. FINLAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 172. FINLAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 173. FINLAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 174. FINLAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 175. FINLAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 176. FINLAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 177. FRANCE COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 178. FRANCE COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 179. FRANCE COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 180. FRANCE COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 181. FRANCE COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 182. FRANCE COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 183. GERMANY COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 184. GERMANY COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 185. GERMANY COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 186. GERMANY COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 187. GERMANY COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 188. GERMANY COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 189. ISRAEL COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 190. ISRAEL COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 191. ISRAEL COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 192. ISRAEL COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 193. ISRAEL COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 194. ISRAEL COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 195. ITALY COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 196. ITALY COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 197. ITALY COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 198. ITALY COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 199. ITALY COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 200. ITALY COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 202. NETHERLANDS COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 203. NETHERLANDS COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 204. NETHERLANDS COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 205. NETHERLANDS COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 206. NETHERLANDS COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 207. NIGERIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 208. NIGERIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 209. NIGERIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 210. NIGERIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 211. NIGERIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 212. NIGERIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 213. NORWAY COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 214. NORWAY COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 215. NORWAY COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 216. NORWAY COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 217. NORWAY COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 218. NORWAY COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 219. POLAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 220. POLAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 221. POLAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 222. POLAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 223. POLAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 224. POLAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 225. QATAR COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 226. QATAR COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 227. QATAR COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 228. QATAR COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 229. QATAR COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 230. QATAR COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 231. RUSSIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 232. RUSSIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 233. RUSSIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 234. RUSSIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 235. RUSSIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 236. RUSSIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 238. SAUDI ARABIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 239. SAUDI ARABIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 240. SAUDI ARABIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 241. SAUDI ARABIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 242. SAUDI ARABIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 244. SOUTH AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 245. SOUTH AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 246. SOUTH AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 247. SOUTH AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 248. SOUTH AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 249. SPAIN COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 250. SPAIN COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 251. SPAIN COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 252. SPAIN COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 253. SPAIN COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 254. SPAIN COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 255. SWEDEN COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 256. SWEDEN COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 257. SWEDEN COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 258. SWEDEN COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 259. SWEDEN COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 260. SWEDEN COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 262. SWITZERLAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 263. SWITZERLAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 264. SWITZERLAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 265. SWITZERLAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 266. SWITZERLAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 267. TURKEY COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 268. TURKEY COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 269. TURKEY COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 270. TURKEY COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 271. TURKEY COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 272. TURKEY COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 274. UNITED ARAB EMIRATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 275. UNITED ARAB EMIRATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 276. UNITED ARAB EMIRATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 277. UNITED ARAB EMIRATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 278. UNITED ARAB EMIRATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 280. UNITED KINGDOM COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 281. UNITED KINGDOM COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 282. UNITED KINGDOM COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 283. UNITED KINGDOM COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 284. UNITED KINGDOM COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 285. COMPUTATIONAL BIOLOGY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 286. COMPUTATIONAL BIOLOGY MARKET, FPNV POSITIONING MATRIX, 2023